(Total Views: 938)
Posted On: 11/30/2020 10:35:10 AM
Post# of 154182
Re: Goosebumps #66657
Goosebumps,
Good day. Hope you all have enjoyed as much as possible the Thanksgiving weekend.
Good set of questions. All very valid & relevant.
For me, the big elephant in the room is Oncology.
Question: can you give us an update in the original EIND patients and those in the basket trial ???
Please remember that a six month increase in OS is deemed a success in Oncology. A CTC reduction will lead indefectibly to such clinical outcome.
We don't have to discover the cure for cancer. We have to probe we have a "signal" as NP put it the other day.
This will be humongous for any company (be it a BP or a pre-revenue) and for cancer sufferers. Global yearly market is around $150 Billion (with B).
So ... please NP tell us something about our cancer patients.
Good day. Hope you all have enjoyed as much as possible the Thanksgiving weekend.
Good set of questions. All very valid & relevant.
For me, the big elephant in the room is Oncology.
Question: can you give us an update in the original EIND patients and those in the basket trial ???
Please remember that a six month increase in OS is deemed a success in Oncology. A CTC reduction will lead indefectibly to such clinical outcome.
We don't have to discover the cure for cancer. We have to probe we have a "signal" as NP put it the other day.
This will be humongous for any company (be it a BP or a pre-revenue) and for cancer sufferers. Global yearly market is around $150 Billion (with B).
So ... please NP tell us something about our cancer patients.
(6)
(0)
